NextCure, Inc. (NXTC) stock
NXTCNasdaqPharmaceutical PreparationsFiscal year ends December 31
$6.70+0.02 (+0.30%)
Close on Nov 17, 2026Market cap $30.67MP/E –Yield 0.00%
NextCure price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
NextCure's price to sales ratio was 10.8× on Apr 30, 2021, against 140.5× a year earlier.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2021 | Apr 30, 2021 | 10.8× | −1.5 |
| 2020 | Dec 31, 2020 | 12.3× | – |
See a number that looks wrong?